Published in Life Sci on June 11, 1979
Psychopharmacological approaches to modulating attention in the five-choice serial reaction time task: implications for schizophrenia. Psychopharmacology (Berl) (2004) 1.22
In utero PCP exposure alters oligodendrocyte differentiation and myelination in developing rat frontal cortex. Brain Res (2008) 0.80
Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats. Psychopharmacology (Berl) (2012) 0.77
Animal Models of Psychosis: Current State and Future Directions. Curr Behav Neurosci Rep (2014) 0.76
Fiber type composition of the vastus lateralis muscle of young men and women. J Histochem Cytochem (2000) 1.67
A corticosteroid receptor in neuronal membranes. Science (1991) 1.66
Opioid receptor subtypes that mediate a microwave-induced decrease in central cholinergic activity in the rat. Bioelectromagnetics (1992) 1.36
The influence of age on the recovery of cardiac monoamine oxidase after irreversible inhibition. Biochem Pharmacol (1968) 1.24
Antillatoxin is a marine cyanobacterial toxin that potently activates voltage-gated sodium channels. Proc Natl Acad Sci U S A (2001) 1.20
The monoamine oxidase catalyzed degradation of phenelzine-l-14C, an irreversible inhibitor of monoamine oxidase--II. Studies in vivo. Biochem Pharmacol (1969) 1.11
The monoamine oxidase catalyzed degradation of phenelzine-l-14C, an irreversible inhibitor of monoamine oxidase--I. Studies in vitro. Biochem Pharmacol (1969) 1.10
Brevetoxin-induced autocrine excitotoxicity is associated with manifold routes of Ca2+ influx. J Neurochem (2000) 1.09
Cardiac monoamine oxidase in rat. Nature (1967) 1.09
Effects of high-intensity resistance training on untrained older men. I. Strength, cardiovascular, and metabolic responses. J Gerontol A Biol Sci Med Sci (2000) 1.04
Domoic acid neurotoxicity in cultured cerebellar granule neurons is mediated predominantly by NMDA receptors that are activated as a consequence of excitatory amino acid release. J Neurochem (1997) 1.01
Pharmacology of thyrotropin-releasing hormone. Annu Rev Pharmacol Toxicol (1986) 0.99
Annular elastolytic giant cell granuloma associated with prostate carcinoma: demonstration of human metalloelastase (MMP-12) expression. Clin Exp Dermatol (2011) 0.99
Antillatoxin and kalkitoxin, ichthyotoxins from the tropical cyanobacterium Lyngbya majuscula, induce distinct temporal patterns of NMDA receptor-mediated neurotoxicity. Toxicon (1999) 0.97
The stress dependent nature of apomorphine hyperthermia in the rabbit. Proc West Pharmacol Soc (1975) 0.97
Thyrotropin-releasing hormone: stimulation of colonic activity following intracerebroventricular administration. Science (1977) 0.96
Florida Red Tide: Inhalation Toxicity of Karenia brevis Extract in Rats. Harmful Algae 2002 (2002) (1) 0.96
Treatment of rats with the TRH analog MK-771. Down-regulation of TRH receptors and behavioral tolerance. Neuropharmacology (1985) 0.96
The neurotoxic lipopeptide kalkitoxin interacts with voltage-sensitive sodium channels in cerebellar granule neurons. Toxicol Lett (2005) 0.95
Synthesis and opioid activity of conformationally constrained dynorphin A analogues. 2. Conformational constraint in the "address" sequence. J Med Chem (1997) 0.95
Guanyl nucleotides modulate binding to steroid receptors in neuronal membranes. Proc Natl Acad Sci U S A (1992) 0.95
Dopaminergic and serotonergic mechanisms of thermoregulation: mediation of thermal effects of apomorphine and dopamine. J Pharmacol Exp Ther (1983) 0.95
Gambierol acts as a functional antagonist of neurotoxin site 5 on voltage-gated sodium channels in cerebellar granule neurons. J Pharmacol Exp Ther (2007) 0.95
Brevetoxins cause acute excitotoxicity in primary cultures of rat cerebellar granule neurons. J Pharmacol Exp Ther (1999) 0.95
Brevetoxin derivatives act as partial agonists at neurotoxin site 5 on the voltage-gated Na+ channel. Brain Res (2003) 0.93
PK 11195 antagonism of pyrethroid-induced proconvulsant activity. Eur J Pharmacol (1986) 0.93
Antillatoxin, a novel lipopeptide, enhances neurite outgrowth in immature cerebrocortical neurons through activation of voltage-gated sodium channels. J Pharmacol Exp Ther (2009) 0.92
Source of extracellular brain adenosine during hypoxia in fetal sheep. Brain Res (1997) 0.92
Characterization of glutamate toxicity in cultured rat cerebellar granule neurons at reduced temperature. J Biochem Toxicol (1996) 0.92
Differential binding properties of [3H]dextrorphan and [3H]MK-801 in heterologously expressed NMDA receptors. Neuropharmacology (2005) 0.92
Orphanin FQ has an inhibitory effect on the guinea pig ileum and the mouse vas deferens. Brain Res (1997) 0.91
Characterization of [3H]MK-801 binding to N-methyl-D-aspartate receptors in cultured rat cerebellar granule neurons and involvement in glutamate-mediated toxicity. J Biochem Toxicol (1996) 0.90
Partial purification and biochemical characterization of a membrane glucocorticoid receptor from an amphibian brain. J Steroid Biochem Mol Biol (2000) 0.90
Microwave irradiation affects radial-arm maze performance in the rat. Bioelectromagnetics (1994) 0.90
Involvement of D1 and D2 dopamine systems in the behavioral effects of cocaine in rats. Pharmacol Biochem Behav (1995) 0.90
Effect of propranolol on the blockade of alpha adrenergic receptors. J Pharmacol Exp Ther (1968) 0.89
Up-regulation of rat cortical adenosine receptors following chronic administration of theophylline. Eur J Pharmacol (1982) 0.89
High affinity [3H]dextrorphan binding in rat brain is localized to a noncompetitive antagonist site of the activated N-methyl-D-aspartate receptor-cation channel. Mol Pharmacol (1992) 0.89
Human skeletal muscle fiber type adaptability to various workloads. J Histochem Cytochem (1984) 0.88
Dextrorotatory opioids induce stereotyped behavior in Sprague-Dawley and Dark Agouti rats. Psychopharmacology (Berl) (1998) 0.88
Low-level microwave irradiations affect central cholinergic activity in the rat. J Neurochem (1987) 0.87
Interaction of dextrorotatory opioids with phencyclidine recognition sites in rat brain membranes. Life Sci (1984) 0.87
N-alkylated derivatives of [D-Pro10]dynorphin A-(1-11) are high affinity partial agonists at the cloned rat kappa-opioid receptor. Eur J Pharmacol (1997) 0.87
Thyrotropin-releasing hormone: neurogenesis of actions in the pentobarbital narcotized rat. J Pharmacol Exp Ther (1980) 0.86
Theophylline-induced upregulation of A1-adenosine receptors associated with reduced sensitivity to convulsants. Neuropharmacology (1987) 0.86
Behaviroal, pharmacological, and molecular characterization of an amphibian cannabinoid receptor. J Neurochem (2000) 0.85
Manipulation of endogenous adenosine in the rat prepiriform cortex modulates seizure susceptibility. J Pharmacol Exp Ther (1993) 0.85
Species comparison of adenosine and beta-adrenoceptors in mammalian atrial and ventricular myocardium. Eur J Pharmacol (1993) 0.85
Centrally administered thyrotropin-releasing hormone (TRH) stimulates colonic transit and diarrhea production by a vagally mediated serotonergic mechanism in the rabbit. J Pharmacol Exp Ther (1982) 0.85
Structure-activity relationships of arodyn, a novel acetylated kappa opioid receptor antagonist. J Pept Res (2005) 0.85
Assessment of skeletal muscle damage in successive biopsies from strength-trained and untrained men and women. Eur J Appl Physiol Occup Physiol (1992) 0.84
Effect of modification of the basic residues of dynorphin A-(1-13) amide on kappa opioid receptor selectivity and opioid activity. J Med Chem (1992) 0.84
Effect of a 42.2-km footrace and subsequent rest or exercise on muscle glycogen and enzymes. J Appl Physiol Respir Environ Exerc Physiol (1983) 0.84
Chlordiazepoxide displaces thyrotropin-releasing hormone (TRH) binding. Eur J Pharmacol (1984) 0.84
Synthesis and evaluation of N,N-dialkyl enkephalin-based affinity labels for delta opioid receptors. J Med Chem (2000) 0.83
Chronic exposure to adenosine receptor agonists and antagonists reciprocally regulates the A1 adenosine receptor-adenylyl cyclase system in cerebellar granule cells. J Neurochem (1996) 0.83
Thyrotropin-releasing hormone (TRH)-induced hyperthermia and behavioral excitation in rabbits. Psychopharmacol Commun (1975) 0.83
Solubilization and pharmacological characterization of a glucocorticoid membrane receptor from an amphibian brain. J Steroid Biochem Mol Biol (1998) 0.83
Differential binding properties of the peripheral-type benzodiazepine ligands [3H]PK 11195 and [3H]Ro 5-4864 in trout and mouse brain membranes. J Neurochem (1989) 0.83
Receptor binding and characterization of TRH receptors. Ann N Y Acad Sci (1989) 0.83
A novel acetylated analogue of dynorphin A-(1-11) amide as a kappa-opioid receptor antagonist. J Med Chem (1999) 0.83
Lipid depletion and repletion in skeletal muscle following a marathon. J Neurol Sci (1989) 0.82
Effects of a 60 Hz magnetic field on central cholinergic systems of the rat. Bioelectromagnetics (1993) 0.82
Synthesis and evaluation of potential affinity labels derived from endomorphin-2. J Pept Res (2003) 0.82
A pimozide-sensitive effect of apomorphine on body temperature of the rabbit. J Pharm Pharmacol (1972) 0.81
Characterization of agonist radioligand interactions with porcine atrial A1 adenosine receptors. Mol Pharmacol (1988) 0.81
Adenosine A1 receptor activation mediates suppression of (-) bicuculline methiodide-induced seizures in rat prepiriform cortex. J Pharmacol Exp Ther (1989) 0.81
Apomorphine: modification of its hyperthermic effect in rabbits by p-chlorophenylalanine. Science (1974) 0.81
Purinergic modulation of the seizure threshold for pentylenetetrazol in the rat. Neuropharmacology (1985) 0.81
Possible role for G-proteins in behavioral sensitization to cocaine. Brain Res (1991) 0.81
Stereoselective L-[3H]quinuclidinyl benzilate-binding sites in nervous tissue of Aplysia californica: evidence for muscarinic receptors. J Neurosci (1985) 0.80
Synthesis and evaluation of isothiocyanate-containing derivatives of the delta-opioid receptor antagonist Tyr-Tic-Phe-Phe (TIPP) as potential affinity labels for delta-opioid receptors. J Med Chem (2000) 0.80
Inhibition of acetylcholine turnover rate in rat hippocampus and cortex by intraventricular injection of adenosine analogs. J Pharmacol Exp Ther (1982) 0.80
High level expression of the NMDAR1 glutamate receptor subunit in electroporated COS cells. J Neurochem (1996) 0.80
Characterization of the preferred stereochemistry for the neuropharmacologic actions of antillatoxin. J Nat Prod (2004) 0.80
Localization of thyrotropin-releasing hormone (TRH) receptors in the septal nucleus of the rat brain. Brain Res (1984) 0.80
N-terminal alkylated derivatives of [D-Pro10]dynorphin A-(1-11) are highly selective for kappa-opioid receptors. J Med Chem (1992) 0.80
Catecholaminergic CATH.a cells express predominantly delta-opioid receptors. Eur J Pharmacol (1998) 0.80
Dermorphin-based potential affinity labels for mu-opioid receptors. J Pept Res (2003) 0.80
Agonist radioligand interactions with the solubilized porcine atrial A1 adenosine receptor. Mol Pharmacol (1989) 0.80
Characterization and distribution of 3H-(3MeHis2)thyrotropin releasing hormone receptors in rat brain. Life Sci (1982) 0.80
Thyrotropin-releasing hormone: central site of action in antagonism of pentobarbital narcosis. Nature (1979) 0.80
Muscle fiber composition and blood ammonia levels after intense exercise in humans. J Appl Physiol Respir Environ Exerc Physiol (1983) 0.80
Synthesis and opioid activity of [D-Pro10]dynorphin A-(1-11) analogues with N-terminal alkyl substitution. J Med Chem (1997) 0.79
Labeling of A1 adenosine receptors in porcine atria with the antagonist radioligand 8-cyclopentyl-1,3-[3H]dipropylxanthine. Eur J Pharmacol (1988) 0.79
Levonantradol-induced inhibition of acetylcholine turnover in rat hippocampus and striatum. J Clin Pharmacol (1982) 0.79
An affinity label for delta-opioid receptors derived from [D-Ala2]deltorphin I. J Pept Res (2004) 0.79
Neuronal location of N6-cyclohexyl[3H]adenosine binding sites in rat and guinea-pig brain. Neuropharmacology (1982) 0.79
Selective brain monoamine oxidase inhibition resulting from an interaction between reversible and irreversible inhibitors. Int J Neuropharmacol (1965) 0.79
Extended TIP(P) analogues as precursors for labeled delta-opioid receptor ligands. J Med Chem (2000) 0.79
Chronotropic responses to catecholamines as a function of monoamine oxidase activity in the isolated perfused rat heart. Arch Int Pharmacodyn Ther (1968) 0.79
Effects of an aerobic exercise program on community-based adults with mental retardation. Ment Retard (1994) 0.79
Interaction of various anesthetic agents with TRH: effects on temperature and arousal in rabbits. Proc West Pharmacol Soc (1976) 0.79
Amino acid neurotransmitter interactions in 'area tempestas': an epileptogenic trigger zone in the deep prepiriform cortex. Epilepsy Res Suppl (1992) 0.79
Temporal relationship between A1 adenosine receptor upregulation and alterations in bicuculline seizure susceptibility in rats. Neurosci Lett (1989) 0.78
Discovery of novel cannabinoid receptor ligands from diverse marine organisms. Adv Exp Med Biol (1997) 0.78
Regional distribution and characterization of [3H]dextrorphan binding sites in rat brain determined by quantitative autoradiography. J Pharmacol Exp Ther (1996) 0.78
Chronic theophylline exposure increases agonist and antagonist binding to A1 adenosine receptors in rat brain. Neuropharmacology (1988) 0.78
Development of pharmacological sensitivity to adenosine analogs in embryonic chick heart: role of A1 adenosine receptors and adenylyl cyclase inhibition. Mol Pharmacol (1989) 0.78